表紙
市場調查報告書

維他命檢驗:醫療設備的開發平台評估

Vitamins Tests - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 640304
出版日期 內容資訊 英文 42 Pages
訂單完成後即時交付
價格
Back to Top
維他命檢驗:醫療設備的開發平台評估 Vitamins Tests - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年11月14日內容資訊: 英文 42 Pages
簡介

本報告提供全球維他命檢查裝置的市場上,主要開發中產品與其臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進展階段) ,及主要企業、組織的簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 等資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 維他命檢驗概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 維他命檢驗:臨床實驗中的開發中產品,各企業

  • 維他命檢驗的企業:各臨床實驗階段的開發中產品
  • 維他命檢驗:各臨床實驗階段的開發中產品

第5章 維他命檢驗市場:企業、產品概要

  • Abbott Diagnostics
    • 開發中產品的資訊,現在進行中的臨床實驗概要
  • Adaltis Srl
  • Beckman Coulter Inc
  • Boditech Med Inc
  • DiaSorin SpA
  • Diatron Medical Instruments Limited
  • Infigo Diagnostics Ltd (Inactive)
  • MyHealthTest Pty Ltd
  • redhot diagnostics AB
  • Roche Diagnostics International Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Siemens Healthcare Diagnostics Inc
  • Siemens Healthineers AG
  • University of Colorado

第6章 維他命檢驗市場:目前的趨勢 (共6件)

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0812EPD

GlobalData's Medical Devices sector report, "Vitamins Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Vitamins Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vitamins Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vitamins Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vitamins Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vitamins Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Vitamins Tests Overview 6

3 Products under Development 7

  • 3.1 Vitamins Tests - Pipeline Products by Stage of Development 7
  • 3.2 Vitamins Tests - Pipeline Products by Segment 8
  • 3.3 Vitamins Tests - Pipeline Products by Territory 9
  • 3.4 Vitamins Tests - Pipeline Products by Regulatory Path 10
  • 3.5 Vitamins Tests - Pipeline Products by Estimated Approval Date 11

4 Vitamins Tests - Pipeline Products under Development by Companies 12

  • 4.1 Vitamins Tests Companies - Pipeline Products by Stage of Development 12
  • 4.2 Vitamins Tests - Pipeline Products by Stage of Development 13

5 Vitamins Tests Companies and Product Overview 14

  • 5.1 Abbott Diagnostics Company Overview 14
    • 5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 Adaltis Srl Company Overview 15
    • 5.2.1 Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.3 Beckman Coulter Inc Company Overview 17
    • 5.3.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 Boditech Med Inc Company Overview 19
    • 5.4.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.5 DiaSorin SpA Company Overview 20
    • 5.5.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.6 Diatron Medical Instruments Limited Company Overview 21
    • 5.6.1 Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.7 Infigo Diagnostics Ltd (Inactive) Company Overview 22
    • 5.7.1 Infigo Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.8 MyHealthTest Pty Ltd Company Overview 23
    • 5.8.1 MyHealthTest Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.9 redhot diagnostics AB Company Overview 24
    • 5.9.1 redhot diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.10 Roche Diagnostics International Ltd Company Overview 25
    • 5.10.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.11 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 30
    • 5.11.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.12 Siemens Healthcare Diagnostics Inc Company Overview 32
    • 5.12.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.13 Siemens Healthineers AG Company Overview 33
    • 5.13.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.14 University of Colorado Company Overview 34
    • 5.14.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 34

6 Vitamins Tests- Recent Developments 35

  • 6.1 Jul 22, 2019: Anteo Diagnostics: Management changes 35
  • 6.2 Apr 15, 2019: Anteo Diagnostics: Strengthens executive team with CEO appointment 35
  • 6.3 Mar 07, 2019: Mindray signs patient safety movement's open data pledge & becomes 90th company to join to improve patient safety 36
  • 6.4 Feb 28, 2019: Anteo Diagnostics: Appointment of CFO and company secretary 37
  • 6.5 Feb 21, 2019: Anteo makes solid progress with GeneoDx partnership 37
  • 6.6 Jan 25, 2019: Introducing DiaSys' new CEO Dr. Jan Gorka 38

7 Appendix 39

  • 7.1 Methodology 39
  • 7.2 About GlobalData 42
  • 7.3 Contact Us 42
  • 7.4 Disclaimer 42

List of Tables

  • Table 1: Vitamins Tests - Pipeline Products by Stage of Development 7
  • Table 2: Vitamins Tests - Pipeline Products by Segment 8
  • Table 3: Vitamins Tests - Pipeline Products by Territory 9
  • Table 4: Vitamins Tests - Pipeline Products by Regulatory Path 10
  • Table 5: Vitamins Tests - Pipeline Products by Estimated Approval Date 11
  • Table 6: Vitamins Tests Companies - Pipeline Products by Stage of Development 12
  • Table 7: Vitamins Tests - Pipeline Products by Stage of Development 13
  • Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 14
  • Table 9: Alinity i Assay - Active B12 - Product Status 14
  • Table 10: Alinity i Assay - Active B12 - Product Description 14
  • Table 11: Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 12: Hemo One - Folic Acid Assay - Product Status 15
  • Table 13: Hemo One - Folic Acid Assay - Product Description 15
  • Table 14: Hemo One - Vitamin B12 Assay - Product Status 16
  • Table 15: Hemo One - Vitamin B12 Assay - Product Description 16
  • Table 16: Hemo One - Vitamin D Assay - Product Status 16
  • Table 17: Hemo One - Vitamin D Assay - Product Description 16
  • Table 18: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 19: Access 2 Immunoassay System - Active B12 - Product Status 17
  • Table 20: Access 2 Immunoassay System - Active B12 - Product Description 17
  • Table 21: UniCel DxI 600 Access Immunoassay System - Active B12 Assay - Product Status 18
  • Table 22: UniCel DxI 600 Access Immunoassay System - Active B12 Assay - Product Description 18
  • Table 23: UniCel DxI 800 Access Immunoassay System - Active B12 Assay - Product Status 18
  • Table 24: UniCel DxI 800 Access Immunoassay System - Active B12 Assay - Product Description 18
  • Table 25: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 26: AFIAS-6 Vitamin D Assay - Product Status 20
  • Table 27: AFIAS-6 Vitamin D Assay - Product Description 20
  • Table 28: DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 29: Diagnostic Test - Vitamin B12 - Product Status 21
  • Table 30: Diagnostic Test - Vitamin B12 - Product Description 21
  • Table 31: Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 32: Diatron Pictus 700 Chemistry-Immunoassay Analyzer - Vitamin D Assay - Product Status 22
  • Table 33: Diatron Pictus 700 Chemistry-Immunoassay Analyzer - Vitamin D Assay - Product Description 22
  • Table 34: Infigo Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 35: MIPdx-B12 - Product Status 23
  • Table 36: MIPdx-B12 - Product Description 23
  • Table 37: MyHealthTest Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 38: Diagnostic Test - Vitamins - Product Status 24
  • Table 39: Diagnostic Test - Vitamins - Product Description 24
  • Table 40: redhot diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 41: Diagnostic Kit - Vitamin B Deficiency - Product Status 25
  • Table 42: Diagnostic Kit - Vitamin B Deficiency - Product Description 25
  • Table 43: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 44: Cobas 6000 Analyzer Series With c 501 Module - Active B12 Assay - Product Status 26
  • Table 45: Cobas 6000 Analyzer Series With c 501 Module - Active B12 Assay - Product Description 27
  • Table 46: Cobas 6000 Analyzer Series With e 601 Module - Active B12 Assay - Product Status 27
  • Table 47: Cobas 6000 Analyzer Series With e 601 Module - Active B12 Assay - Product Description 27
  • Table 48: Cobas 8000 Analyzer Series With c 502 Module - Active B12 Assay - Product Status 27
  • Table 49: Cobas 8000 Analyzer Series With c 502 Module - Active B12 Assay - Product Description 28
  • Table 50: Cobas 8000 Analyzer Series With c 701 Module - Active B12 Assay - Product Status 28
  • Table 51: Cobas 8000 Analyzer Series With c 701 Module - Active B12 Assay - Product Description 28
  • Table 52: Cobas 8000 Analyzer Series With c 702 Module - Active B12 Assay - Product Status 29
  • Table 53: Cobas 8000 Analyzer Series With c 702 Module - Active B12 Assay - Product Description 29
  • Table 54: Cobas 8000 Analyzer Series With e 602 Module - Active B12 Assay - Product Status 29
  • Table 55: Cobas 8000 Analyzer Series With e 602 Module - Active B12 Assay - Product Description 29
  • Table 56: Cobas 8000 Analyzer Series With e 801 Module - Active B12 Assay - Product Status 30
  • Table 57: Cobas 8000 Analyzer Series With e 801 Module - Active B12 Assay - Product Description 30
  • Table 58: Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 59: CL-1000i - Vitamin B12 Test - Product Status 31
  • Table 60: CL-1000i - Vitamin B12 Test - Product Description 31
  • Table 61: CL-2000i - Vitamin B12 Test - Product Status 32
  • Table 62: CL-2000i - Vitamin B12 Test - Product Description 32
  • Table 63: Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 64: Dimension EXL System - LOCI B12 Assay - Product Status 33
  • Table 65: Dimension EXL System - LOCI B12 Assay - Product Description 33
  • Table 66: Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 67: ADVIA Centaur CP Immunoassay System - Active B12 Assay - Product Status 34
  • Table 68: ADVIA Centaur CP Immunoassay System - Active B12 Assay - Product Description 34
  • Table 69: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 70: Sulfhydryl Amino-acid Assay - Product Status 36
  • Table 71: Sulfhydryl Amino-acid Assay - Product Description 36
  • Table 72: Glossary 45

List of Figures

  • Figure 1: Vitamins Tests - Pipeline Products by Stage of Development 7
  • Figure 2: Vitamins Tests - Pipeline Products by Segment 8
  • Figure 3: Vitamins Tests - Pipeline Products by Territory 9
  • Figure 4: Vitamins Tests - Pipeline Products by Regulatory Path 10
  • Figure 5: Vitamins Tests - Pipeline Products by Estimated Approval Date 11
Back to Top